These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24597)

  • 1. Comparative potency of intravenous penbutolol and propranolol in man.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):83-5. PubMed ID: 24597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thromboxane B2 after intravenous administration of talinolol and propranolol in healthy subjects.
    Sziegoleit W; Block HU; Fahr A; Mest HJ
    Pharmazie; 1991 Jan; 46(1):58-9. PubMed ID: 1677468
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-2 adrenoceptor blocking activity of penbutolol and propranolol at very low doses.
    Kulkarni RD; DaSilva LM; Chabria NL; Chadha DR
    Clin Pharmacol Ther; 1977 Jun; 21(6):685-90. PubMed ID: 16716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effect of intravenous administration of atenolol and practolol on resting and exercise-evoked increase in heart rate and cardiac work load in normal human subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):27-30. PubMed ID: 838525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a signle oral dose.
    Westheim AS; Christensen CC; Kjekshus J
    Eur J Clin Pharmacol; 1978 May; 13(3):157-62. PubMed ID: 27370
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of acebutolol, a new beta-receptor antagonist on heart rate and rate-pressure product in normal subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):290-7. PubMed ID: 1002366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
    Hillis WS; Tweddel AC; Murray RG; Lawrie TD
    Arzneimittelforschung; 1980; 30(9):1595-9. PubMed ID: 7006619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bisoprolol with other beta-adrenoceptor blocking drugs.
    Krämer B; Balser J; Stubbig K; Krämer G; Kübler W
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S46-57. PubMed ID: 2439798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man.
    Bax ND; Jones RW; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):593-6. PubMed ID: 4005101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extent of beta-blocking action of S- and R-penbutolol during exercise testing (author's transl)].
    Kober G; Schulz W; Hermann HJ; Kaltenbach M
    Z Kardiol; 1982 Apr; 71(4):289-94. PubMed ID: 6283753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
    Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the duration of the effect of a single dose of nadolol on the product frequency x tension during exercise (author's transl)].
    Donzeau JP; Birmacker A; Bernadet P; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1978 Oct; 27(5):407-9. PubMed ID: 32825
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamic and kinetic comparison of penbutolol and propranolol in healthy volunteers [proceedings].
    Baird IM; Hill H; Ings RM; Johnson KI; McEwen J
    Br J Clin Pharmacol; 1977 Jun; 4(3):386P. PubMed ID: 20121
    [No Abstract]   [Full Text] [Related]  

  • 18. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
    Hansson BG; Hökfelt B
    Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
    Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic sympathomimetic activity of penbutolol.
    Nyberg G; Wilhelmsson C; Vedin A
    Eur J Clin Pharmacol; 1979; 16(6):381-6. PubMed ID: 43255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.